Aspirin Exacerbated Respiratory Disease and Nasal Polyp Phenotyping

Document Type : Research article

Authors

1 Otolaryngology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

2 Allergy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

3 Department of Allergy and Clinical Immunology, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran.

4 Department of Pathology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.

5 Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.

6 Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.

10.22037/ijpr.2021.114924.15113

Abstract

Aspirin exacerbated respiratory disease (AERD) is known by the triad of chronic rhinosinusitis with nasal polyposis (CRSwNP), aspirin hypersensitivity, and asthma, but its etiology and physiopathogenesis are still unclear. This cross-sectional study was designed to investigate allergy and inflammatory cells (neutrophils vs. eosinophils) dominancy in nasal polyp tissue of patients with AERD compared to non-AERD patients. CRSwNP patients scheduled for endoscopic sinus surgery were recruited in this study. Nasal polyp tissue was analyzed for infiltrating cells, and Eosinophil dominant and neutrophil dominant polyps were determined. AERD was confirmed by oral aspirin challenge (OAC). Demographics data; history of asthma, exacerbation by using NSAIDs, routine use of aspirin, type of surgery (primary or revision), and results of skin prick test and spirometry were recorded. Pathology results and contributing factors compared between AERD and non-AERD patients. Sixty-five patients (39 women, 26 men) were enrolled in the study (mean age 38.83 ± 12.43 years). Thirty (46%) patients had positive OAC tests. Totally 41 patients (63.1%) had eosinophilic polyps. 80% of patients with eosinophilic polyp had positive OAC and were AERD (P < 0.05). There was no significant difference in demographics, revision surgery, and concomitant asthma between AERD and non-AERD groups (P > 0.05). The positive skin prick test was higher in AERD and also in eosinophilic polyp patients, but it was not statistically significant (P = 0.086 and P = 0.177). Eosinophilic polyps are more common in AERD. A positive skin prick test is associated with AERD and eosinophilic polyp.

Graphical Abstract

Aspirin Exacerbated Respiratory Disease and Nasal Polyp Phenotyping

Keywords

References

Fokkens WJ, Lund VJ, Hopkins C, Hellings, PW, Kern
R, Reitsma S, Toppila-Salmi S , Bernal-Sprekelsen
M, Mullol J, Alobid I, Terezinha Anselmo-Lima
W, Bachert C, Baroody F, Buchwald C, Cervin A,
Cohen N, Constantinidis J, Gabory L, Desrosiers
M, Diamant Z , Douglas RJ, Gevaert PH, Hafner
A, Harvey RJ and Farrokhi s. European Position
Paper on Rhinosinusitis and Nasal Polyps 2020.
Rhinology (2020) 58: 1-464.
(2) DeConde AS and Soler ZM. Chronic rhinosinusitis:
Epidemiology and burden of disease. Am. J.
Rhinol. Allergy (2016) 30: 134-9.
(3) Stevens WW, Schleimer RP and Kern RC. Chronic
Rhinosinusitis with Nasal Polyps. J. Allergy Clin.
Immunol. Pract. (2016) 4: 565-72.
(4) Nabavi M, Esmaeilzadeh H, Arshi S, Bemanian
MH, Fallahpour M, Bahrami A, Mortazavi N,
Kamrava K, Farhadi M, Taghipour R and Rezaei
N. Aspirin hypersensitivity in patients with chronic
rhinosinusitis and nasal polyposis: frequency and
contributing factors. Am. J. Rhinol. Allergy (2014)
28: 239-43.
(5) Bachert C, Zhang L and Gevaert P. Current and future
treatment options for adult chronic rhinosinusitis:
Focus on nasal polyposis. J. Allergy Clin. Immunol.
(2015) 136: 1431-40.
(6) Li KL, Lee AY and Abuzeid WM. Aspirin
exacerbated respiratory disease: epidemiology,
pathophysiology, and management. Med. Sci.
(2019) 7: 45.
(7) Garcia Cruz ML, Jimenez-Chobillon MA and Teran
LM. Rhinosinusitis and aspirin-exacerbated
respiratory disease. J. Allergy (2012) 27: 37-52.
(8) Peters AT, Spector S, Hsu J, Hamilos DL, Baroody
FM, Chandra RK, Grammer LC, Kennedy DW,
Cohen NA, Kaliner MA, Wald ER, Karagianis
A and Slavin RG. Diagnosis and management of
rhinosinusitis: a practice parameter update. Ann.
Allergy Asthma Immunol. (2014) 113: 347-85.
(9) Stevens WW, Peters AT, Hirsch AG, Nordberg
 
27AERD and Nasal Polyp Phenotype
CM, Schwartz BS, Mercer DG, Mahdavinia M,
Grammer LC, Hulse KE, Kern RC, Avila P and
Schleimer RP. Clinical Characteristics of Patients
with Chronic Rhinosinusitis with Nasal Polyps,
Asthma, and Aspirin-Exacerbated Respiratory
Disease. J. Allergy Clin. Immunol. Pract. (2017) 5:
1061-70.
(10) Schleimer RP. Immunopathogenesis of Chronic
Rhinosinusitis and Nasal Polyposis. Annu. Rev.
Pathol. (2017) 12: 331-57.
(11) Pezato R, Swierczynska-Krepa M, Nizankowska-
Mogilnicka E, Holtappels G, De Ruyck N, Sanak
M, Derycke L, Crombruggen KV, Bachert C
and Pérez-Novoa CA. Systemic expression of
inflammatory mediators in patients with chronic
rhinosinusitis and nasal polyps with and without
Aspirin Exacerbated Respiratory Disease. Cytokine
(2016) 77: 157-67.
(12) Nabavi M, Arshi S, Bahrami A, Aryan Z, Bemanian
M, Esmaeilzadeh H, Jalali F, Pousti FB and
Rezaei N. Increased level of interleukin-13, but
not interleukin-4 and interferon-γ in chronic
rhinosinusitis with nasal polyps. Allergol.
Immunopathol. (2014) 42: 465-71.
(13) Tokunaga T, Sakashita M, Haruna T, Asaka D,
Takeno S, Ikeda H, Nakayama T, Seki N, Ito S,
Murata J, Sakuma Y, Yoshida N, Terada T, Morikura
I, Sakaida H, Kondo K, Teraguchi K, Okano M,
Otori N, Yoshikawa M, Hirakawa K, Haruna S,
Himi T, Ikeda K, Ishitoya J, Iino Y, Kawata R,
Kawauchi H, Kobayashi M, Yamasoba T, Miwa
T, Urashima M, Tamari M, Noguchi E, Ninomiya
T, Imoto Y, Morikawa T, Tomita K, Takabayashi T
and Fujieda S. Novel scoring system and algorithm
for classifying chronic rhinosinusitis: the JESREC
Study. Allergy (2015) 70: 995-1003.
(14) Kim SJ, Lee KH, Kim SW, Cho JS, Park YK and
Shin SY. Changes in histological features of nasal
polyps in a Korean population over a 17-year
period. Otolaryngol-Head Neck Surg. (2013) 149:
431-7.
(15) Rajan JP, Wineinger NE, Stevenson DD and White
AA. Prevalence of aspirin-exacerbated respiratory
disease among asthmatic patients: a meta-analysis
of the literature. J. Allergy Clin. Immunol. (2015)
135: 676-81.
(16) Fan Y, Feng S, Xia W, Qu L, Li X, Chen S, Ding M,
Lai Y, Shi J, Xu G and Li H. Aspirin-exacerbated
respiratory disease in China: a cohort investigation
and literature review. Am. J. Rhinol. Allergy (2012)
26: 2-20.
(17) Esmaeilzadeh H, Nabavi M, Amirzargar AA,
Aryan Z, Arshi S, Bemanian MH, Fallahpour M,
Mortazavi N and Rezaei N. HLA-DRB and HLA-
DQ genetic variability in patients with aspirin-
exacerbated respiratory disease. Am. J. Rhinol.
Allergy (2015) 29: 63-9.
(18) Laidlaw TM. Clinical updates in aspirin-exacerbated
respiratory disease. Allergy Asthma Proc. (2019)
40: 4-6.
(19) Al Jobran BS, Alotaibi AE, Asiri AY, Alhayyani
RM and Almanie NI. Nasal Polyps and its Histo-
pathological Evaluation. Egypt J. Hosp. Med.
(2018) 70: 2022-5.
(20) Zhang Y, Gevaert E, Lou H, Wang X, Zhang L,
Bachert C and Zhang N. Chronic rhinosinusitis in
Asia. J. Allergy Clin. Immunol. (2017) 140: 1230-
9.
(21) Ikeda K, Shiozawa A, Ono N, Kusunoki T,
Hirotsu M, Homma H, Saitoh T and Murata J.
Subclassification of chronic rhinosinusitis with
nasal polyp based on eosinophil and neutrophil.
Laryngoscope (2013) 123: 1-9.
(22) Lou H, Meng Y, Piao Y, Wang C, Zhang L and
Bachert C. Predictive significance of tissue
eosinophilia for nasal polyp recurrence in the
Chinese population. Am. J. Rhinol. Allergy (2015)
29: 350-6.
(23) Tecimer SH, Kasapoglu F, Demir UL, Ozmen OA,
Coskun H and Basut O. Correlation between clinical
findings and eosinophil/neutrophil ratio in patients
with nasal polyps. Eur. Arch. Otorhinolaryngol.
(2015) 272: 915-21.
(24) Wen W, Liu W, Zhang L, Bai J, Fan Y, Xia W, Luo Q,
Zheng J, Wang H, Li Z, Xia J, Jiang H, Liu Z, Shi
J, Li H and Xu G. Increased neutrophilia in nasal
polyps reduces the response to oral corticosteroid
therapy. J. Allergy Clin. Immunology (2012) 129:
1522-8.
(25) Kong IG and Kim DW. Pathogenesis of recalcitrant
chronic rhinosinusitis: the emerging role of innate
immune cells. Immune Netw. (2018) 18: 1-12.
(26) Ahmadiafshar A, Farjd HR, Moezzi F and
Mousavinasab N. Nasal polyposis in patients with
asthma and allergic rhinitis. J. Laryngol. Otol.
(2012) 126: 780-3.
(27) Lin DC, Chandra RK, Tan BK, Zirkle W, Conley
DB, Grammer LC, Kern RC, Schleimer RP and
Peters AT. Association between severity of asthma
and degree of chronic rhinosinusitis. Am. J. Rhinol.
Allergy (2011) 25: 205-8.
(28) Fan Y, Chen S, Qu X, Zuo K, Li X, Huang J,
GengX, Mi J and Li H. A lower prevalence of
asthma among patients with chronic rhinosinusitis
in southern China. J. Allergy Clinical Immunol.
(2011) 127: 520-2.
(29) Rajan JP, Wineinger NE, Stevenson DD and White
AA. Prevalence of aspirin-exacerbated respiratory
 
28
Kaboodkhani R et al. / IJPR (2021), 20 (4): 21-28
disease among asthmatic patients: a meta-analysis
of the literature. J. Allergy Clin. Immunol. (2015)
135: 676-81.
(30) Esmaeilzadeh H, Esmaeilzadeh E, Faramarzi
M, Nabavi M and Farhadi M. Salicylate food
intolerance and aspirin hypersensitivity in nasal
polyposis. Iran. J. Immunol. (2017) 14: 81-8.
(31) Mortazavi N, Esmaeilzadeh H, Abbasinazari
M, Babaie D, Alyasin S, Nabavizadeh H and
Esmaeilzadeh E. Clinical and immunological
efficacy of aspirin desensitization in nasal polyp
patients with aspirin-exacerbated respiratory
disease. Iran. J. Pharm. Res. (2017) 16: 1639-47.
(32) Esmaeilzadeh H, Nabavi M, Aryan Z and Amirzargar
AA. Pharmacogenetic tests to predict the efficacy
of aspirin desensitization in patients with aspirin-
exacerbated respiratory diseases; HLA-DQB302.
Expert Rev. Respi. Med. (2015) 9: 511-8.
(33) Esmaeilzadeh H, Nabavi M, Aryan Z, Arshi S,
Bemanian MH, Fallahpour M and Mortazavi N.
Aspirin desensitization for patients with aspirin-
exacerbated respiratory disease: A randomized
double-blind placebo-controlled trial. Clin.
Immunol. (2015) 160: 349-57.
(34) Arshi S, Nabavi M, Bemanian MH, Shakeri R,
Taghvaei B, Ghalebaghi B, Babaie D, Bahrami
A, Fallahpour M, Esmaeilzadeh H, Rekabi M,
Amadian J, Eslami N, Shokri S, Jalali F, Akbarpour
N, Molatefi R and Rezaei N. Phenotyping and
follow up of forty-seven Iranian patients with
common variable immunodeficiency. Allergol.
Immunopathol. (2016) 44: 226-3
Iranian Journal of Pharmaceutical Research
Volume 20, Issue 4
Autumn 2021
Pages 21-28

Files

Share

How to cite

Statistics